BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Letter to Shareholders
Jan 3, 2023
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, has published a letter from CEO Amir Reichman. The letter provides an overview of 2022 accomplishments, including the company’s successful preclinical trial results of the inhaled COVID-19 NanoAb therapy, along with a report of recent financing activities to support 2023 objectives. Highlights of the letter include the signing a series of collaboration agreements with the Max Planck Institute for Multidisciplinary Sciences (“MPI”) and the University Medical Center Göttingen, Germany (“UMG”) for the development of NanoAbs addressing diseases with large unmet medical needs that also have commercial potential such as asthma, psoriasis, psoriatic arthritis, and macular degeneration, in addition to the COVID-19 program signed in Q4 2021. BiondVax also signed a definitive amendment to its existing loan agreement with the European Investment Bank that extends the maturity of its €24 million loan until Dec. 31, 2027, and initiated discussions with potential clients interested in hiring the company as a contract development and manufacturing organization. In addition, the company reported the successful first readout results in the preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy. “BiondVax’s 2022 achievements leave me incredibly optimistic about BiondVax’s growth potential and ability to deliver value to our stakeholders,” stated BiondVax Pharmaceuticals CEO Amir Reichman in the letter. “With funding in place to continue development, our plans include executing several steps required to bring our inhaled COVID-19 NanoAb therapy into a first-in-human phase 1/2a clinical trial by the end of 2023. These steps include toxicology studies and GMP manufacturing of the NanoAb. We also intend to exercise our option to obtain an exclusive license at preagreed financial terms to anti-IL-17 NanoAbs from our partners in Germany, scale up in-house NanoAb manufacturing, conduct an in vitro proof-of-concept study and potentially also a preclinical trial of the IL-17 NanoAb as a therapy for psoriasis. . . . I believe we have set the stage in 2022 for a highly successful 2023. The BiondVax team, in collaboration with our scientific partners from MPI and UMG, has worked exceedingly hard to develop the company into a global leader in NanoAb technology.”
To view the full press release, visit https://ibn.fm/98sd7
About BiondVax Pharmaceuticals Ltd.
BiondVax Pharmaceuticals, a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Since its inception, the company has executed eight clinical trials including a seven-country, 12,400-participant, phase 3 trial of its prior vaccine candidate; the company has also built a state-of-the-art manufacturing facility for biopharmaceutical products. With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nonosized antibody (“NanoAb”) pipeline. For more information about the company, please visit www.BiondVax.com
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Jeepney operator summoned over ‘hit-and-run’ incident involving cyclist
(Photo: LTFRB) MANILA, Philippines — The Land Transportation Franchising and Regulatory Board (LTFRB) has summoned the operator of a passenger jeepney whose driver allegedly fled after hitting a cyclist in Quezon City. The Land Transportation Office (LTO), meanwhile, issued a show-cause order against the driver and registered owner of the jeepney following the incident. In
Abandoned motorcycle leads cops to judge’s slay suspects
PAGADIAN CITY — A motorcycle abandoned in Barangay Maasin, Zamboanga City has led police investigators to the suspects in the ambush of Judge Joseph Wee Sit early on Thursday. On Saturday afternoon, the police had filed criminal complaints against three suspects before the Zamboanga City Prosecutor’s Office. Lt. Col. Shellamie Chang, spokesperson of the Police
Protesters, police clash in Manila during Asean Summit protest
MANILA, Philippines — What was meant to be a peaceful protest coinciding with the start of the 49th Association of Southeast Asian Nations (Asean) Summit on Sunday escalated into a tense confrontation between rallyists and police, with protesters claiming that authorities were trying to sabotage their program. The protests were slated to start as early
Prince William to be joined by wife Kate for visit to India
Kate, Princess of Wales, will undertake her biggest foreign trip since having treatment for cancer when she joins her husband Prince William in India for his annual Earthshot Prize awards.
400 Nueva Ecija cops deployed to secure 2026 Asean Summit
CAMP GEN. MARIANO N. LLANERA, Nueva Ecija — At least 400 police officers from the Nueva Ecija Police Provincial Office (NEPPO) have been deployed to the National Capital Region (NCR) to augment security forces for the 2026 Association of Southeast Asian Nations (Asean) Summit, police said Saturday, Nov. 14. A send-off ceremony was held at
Super El Niño puts Ilocos Sur town under state of calamity
SAN ILDEFONSO, Ilocos Sur — The municipality of Santa Maria in this province was placed under a state of calamity early this week due to extensive damage to agricultural crops caused by a prolonged drought associated with Super El Niño, with losses estimated at over P48 million. Mayor Michael Florendo, who sought the declaration, said
TransCo to Mindoro consumers: Avoid unnecessary power consumption
CALAPAN CITY, Oriental Mindoro — The National Transmission Corporation (TransCo) said that households and businesses in Mindoro can help manage electricity supply amid a possible strong El Niño by cutting down on unnecessary power use, especially during the dry season when hydropower output may drop. TransCo President and Chief Executive Officer Atty. Joseph Omar Castillo
PCSO Lotto Results: No winners of major games; Ultra Lotto jackpot at P537.9 million
The jackpot for the Ultra Lotto 6/58 game has reached P537.9 million, but there were no winners of either of the major lotto games on Sunday, Nov. 15, 2026.
LOOK: PH eyes stronger trade, agricultural ties with Thailand
President Ferdinand R. Marcos Jr. met with Thai Prime Minister Anutin Charnvirakul and discussed a wider economic cooperation and possibly establishing stronger trade and agricultural ties.
Cyprus, Slovakia, Slovenia join ASEAN Treaty of Amity and Cooperation
The Republic of Cyprus, the Slovak Republic, and the Republic of Slovenia have formally joined ASEAN"s Treaty of Amity and Cooperation in Southeast Asia (TAC) on Saturday, November 14, 2026.
LOOK: PH, Laos look to deepen cooperation, open opportunities for Filipinos
President Ferdinand R. Marcos Jr. discussed cooperation with Lao People"s Democratic Republic (PDR) Prime Minister Saleumxay Kommasith on various sectors such as trade, labor, education, and vocational training, according to the Presidential Communications Office (PCO).
Heat index in parts of Eastern Visayas expected to increase
TACLOBAN CITY — Borongan City and Guiuan in Eastern Samar are expected to record a heat index of up to 42 degrees Celsius, classified as “danger,” on Nov. 15, as high temperatures persist in several areas of Eastern Visayas, the state weather bureau said. Tacloban City and Catarman in Northern Samar are expected to record
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.